{"ticker": {"uuid": "5587aa83-55ce-4469-b222-200a992d9332", "symbol": "GILD34", "name": "Gilead Sciences, Inc.", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Insider Sell: Johanna Mercier Sells Shares of Gilead Sciences In", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNRDJINzNmRWp6N3NUdGtmN2dKOFMtaWdfNEFMbnk3dC1YdWNMa2RkQmJwSHoycWVpZTFfdkFRaXlZVlJaUzBuNnRGRnZ3YlJkRnJvQ1R1VDVpYURIYVM0LVI5SGxMUFl2VWVGLWJsaEJGVnQ0aUlnZWpkNk9HR1NVOF83NURJZXFtTkJZX2ZXNWxmeEgySm1UOWJaMFVSWTlWV2RSX3JSSXZlTkdY?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T23:08:26+00:00", "published_display": "16 Jul 2026 23:08", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences chief comm & corp aff officer sells $389,757 in stock By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNOF9sTldncUxBeDF2WXFWU2FXdDVIMndFMlFaOHQ3SUZUbTU2bmdROEE4cWJ1MUtqcUE3T093MXVSVFBOM1R2cWN5SUVWbWNyQVhIOGdfVmlSc0NGdWZqNUNRZzRDZE1ZeGpwb1NJWGhVSUV2UmJiRDhxVGc0ZUFwVDFQdTdrUzdrSlN4bWNCQ0NoT25TYkg5bVlSRDR0dElkaU5RSEd6a0F2R193N0VCejByM2NYUkNwai1rYzY5MnhLODl2ZkE?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-07-16T22:21:52+00:00", "published_display": "16 Jul 2026 22:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Inc (GILD) Stock Up 3.5% but GF Value Says Overv", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxObUJabGVPbXJTRnMycU9vSmp1Q0RCZExIZUNPbUhMbno0QW1tTllEYnNoOU1KS3k5TGFNYlc0RU5EMlRYMGpKbFRFUHdnQzFaX0prLWxJTHduRldEYnkzeDRUd25DZjRlS3o1Z19JcElPemNQamNTSl9FRDdEUFo2Y0tqQlNDaGFJWS16OUZQVjJyeWZncjlOM1gxNUpSQnJuMkNEc0JvdDRndmVZTThoLXpNOXE3ejNIb1dV?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T21:35:27+00:00", "published_display": "16 Jul 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look at Gilead Sciences Inc (GILD) After 3.7% Decline -- GF Va", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNeUd1bkVMbTFpMVI5QUEzdFByTHN4b1FLZVZUS1ZXbjRISGUzampEemMxa3VQdXVkckdHQnVva3MwOWNDdjRSZU02QTNGVE9SalF4R2R5WFg5cnVIN3RKU3J3V1RrM2laUDllRzNiWE1WaUlDYTVaaVRvS1VWaHd6U1NKVmdMUW9NMFlGTkJpZFpPMXNQSmZwaFZ4LTExYVZWUnZ4MlVqalpjUXVkQTFGUkNjMUtuTzdJZDVsdGVkZXVEOWJDaWFMVzFqSQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-10T21:24:14+00:00", "published_display": "10 Jul 2026 21:24", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Johanna Mercier Sells 3,000 Shares of Gilead Scien", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQS0JEQVlHbk01WDlsbnhYMkg3QVhNZDFEUFd1SGVveHkxSzVTWDhxazN1dEJvYTdTMEVKcER2UWJKVUQxMGV0TzFYcnRIYWllUW9zSHYwOE9oeDRtdlJWTFl4YjlXMHJhY2doa2JuY1RIQUxxT1NQdGZKVFdZajBoMjR1UUo2cmRyYWRoSnhMVzBNOG50S3M4b2JhelFYOTRVaGkyQngxaE55VmtmMUYzZmlJMHM5TE56RzR6eWYtTEU4TFU?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Daniel O'Day Sells 15,000 Shares of Gilead Sciences Inc (GILD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQWXBuQU92NGVfOGIzMVJjaFl2UzVmY3ZPZktmaUI4Z194S0cxMDg3T0lCVWROdV8wUld5aF9Ua1ZHQkM2RVJsN3NNRW1xMlpFai0zUEdQNUJXU18wZnQ0X2dKLXRRV2JMelJrTzFVUk1YbzZmRlpUelFjS2VCMFd0VWJ2dHg3bjdsRERQeWsxcl9xOU53RVA3OGIya1NpTTNtdlBWMlZ5dFBBZFN0bUV0QXpWaEFURklNRWlSX2tsZEhfY2xhZ1JYNVRIRXVLbTh0cENldA?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Reports Strong Q1 2026 Earnings and Raises Sales Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPZFNGNmpFU1hndi12dG1yNzlickgwX3J5VkxFdkpqZXZfb3dVVTV5SWpUN19JUFBmYUpTQUhtdF9jZk5QWDl4LTdfVHlzZDJxTTBPTHI2clpFbUZMVWhoeVYtRThVeXI2ZUZjaVc5Y2NjbEZFZlNrYlNDS3NuUmw1RVZkY3YwWjNKYVFQcmo4RFpRdHpiZk1pY08zcDJMM21Ub3ZNN2RSekRuVlRyNTFQSFBHZXBKamk2SVJXTmdnZ0JkRDBURFVOeA?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Stock Outlook: Is Wall Street Bullish or Bearish?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOOGNnUEttRXREWXJQRjdNd3MzRmswdlA2VjJqMGhadnRzYUdIdG14NGdmQmdybnN5SENoeHVRWExMR2R1eGRkZThBeGxmZUEweVhUbTNsSnQ3NnQzUjdUYUxmUzNyNDNlNmJBWXI3N3d5Mm1yUWlVWW42YlB0OGd3aTZaZmdaME04V3JnZDRfYzhURFVBcWtCN0xjZ2tRb3dlMDlRdEx4MVdaTW8?oc=5", "source_name": "Barchart.com", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences to acquire Ouro Medicines, expanding autoimmune therapy portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxOSXZZV054UjFMS0JyZU85R1JUdnVrOUcyRjlOTVVkb19aNGZaOXBWeVYtQ1ZVampka05DRzNuTmpSREw2ai1yUWhKV090dG9mQnVxYUNpU2pnTEplWlF4RE1oaUVsRTBGX1M5TnUtb193aGhqa21aUHA0MEdmUkZ6N3dlNG8wNWttTWc1aUF5bmtfS1ZtVGdxZndNclNfSmFualRlWmFGR2JQNjI2RnA2VGNKVWJCN2xwU1NRSFIzaU5kZEh2T09zR3ZjS3lqYUZ5ZVdDa3pJZDA4QWhqU0Qyazl4TzlSZw?oc=5", "source_name": "Proactive financial news", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxNSHF3TjZVc0plaEN3eU5QdFY0UGhrN3UwTnBVZmVweW4yOGw0a0ZETDBrWHdPQ1luanBsdG9fQTRSbXI5aDNuTTgxV2p2anlzOEJ0bEJ0cGh2b2JBc1U5UFY1M2l6amxFc2l0bmliMkx4czNBRmN0dEFTcktjeVN1eU5oVVMzb2IxbUtPZENvWGw5RXc0RjBmOUdMVUd4RTh6OVJzN3BfcWo2a0QxUE9BWGdJckEwSFRSRlpoWnpNbG5ZcE5PVUdrWFZSN0pmVldGN3Y3SmktSU1Dd05NdkZyTWdGc0FjaEx6Z1NndHo3VFd0SFRj?oc=5", "source_name": "PR Newswire", "published_at": "2025-07-22T07:00:00+00:00", "published_display": "22 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead commits to HIV prevention rollout for low-income countries despite funding uncertainty", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxQdTJtdkdTb0JvbXNVeElyQkFzN2JLRy0yQXhPWkYyaXU0Rms4d2NfRVl6MnZaeEI5emp2Y1VCM0k3cWZnT181QURLOUtiZXJrMmxRLURKaEs3WkliblEtNmlsM0txSTc0eU1MT1NiLWtTZTI2c1E1UXhGbjBRQ3pjS3ZqTWRIRnA3bWk4NTI5VjZNQnJHTlk3NlVvcFFPOWF2N3RSYllNTVpEeUdvREl6c0IzeXduOUpEVnZyR0I0TE52cDRNVnA4dXdUVjZETFpGdjRvMTVGQU5SRVRQcTRj?oc=5", "source_name": "Reuters", "published_at": "2025-05-30T07:00:00+00:00", "published_display": "30 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GILEAD SCIENCES APPOINTS PAUL PETRELLI TO VICE PRESIDENT AND GENERAL MANAGER IN CANADA", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxONm5PVmQ2Zjl1MjdabUlSMVE2NDFUTUI0bnpCNWxXUkN2N2ROb0dVbFotNnBwelRhYnlaYTdVeTZDWUFkaU0wZWJQRVpKTjhPbnhmRUlzTFBzOXg5RER5Rl90YV9NN21oUlNDY3hZb2ZleFRrQUQyUXlIN3F2ZnJMN1psMnBIZ2l2NFM5Y2t6U0hNMjZ0Tm12ekxhTmQ0d2h0QkNEeDlqdm85ZHBZZ0xxMHM3X1M2YVBZazEyYUZQYVVZVnZJOGtEVG11TkhwNnp1SVJfMHlB?oc=5", "source_name": "PR Newswire Canada", "published_at": "2024-11-07T08:00:00+00:00", "published_display": "07 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Inc (GILD:UW): Stock Price, Quote and News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE9IVGpORkxhRm1oN3hiY0FMLTlNb2RMemFWeGdNYzJfSGNhcGQ2NFFvUXNVRmF5WUl0NXk0eF94TFo0RnY1RmZHQ1oyOW9IWkpUWk1WUQ?oc=5", "source_name": "BNN Bloomberg", "published_at": "2024-07-30T16:12:03+00:00", "published_display": "30 Jul 2024 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brazil court strips Gilead of hepatitis C drug patent", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOYU85Z3NlWXk0TVk4TjVINDM4RWcycUxzYmhFdVVOMWk1eUVtTGtJc3loTEhmdlJRZ0FIcHd2bDBTWFJWNC1zZFdXQWkzRmlPak4tZlFSNnpJdVU4SUlrM0t3dWxMaVJJN3lGUU5OMDctOGR0X0tVSjdSa3RRSEtDRzlCd3J5OVcxQ0M5VXhzMFQ3X2c5N1MtOWJKblRoa2dZX3BIWm1CeE5xZWlyc2tIRHFfVE9JYmYxOHphTFlNamhLWVZpOS1LRXBvZWduSndpSFE?oc=5", "source_name": "Reuters", "published_at": "2018-09-24T07:00:00+00:00", "published_display": "24 Sep 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Insider Sell: Johanna Mercier Sells Shares of Gilead Sciences In", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNRDJINzNmRWp6N3NUdGtmN2dKOFMtaWdfNEFMbnk3dC1YdWNMa2RkQmJwSHoycWVpZTFfdkFRaXlZVlJaUzBuNnRGRnZ3YlJkRnJvQ1R1VDVpYURIYVM0LVI5SGxMUFl2VWVGLWJsaEJGVnQ0aUlnZWpkNk9HR1NVOF83NURJZXFtTkJZX2ZXNWxmeEgySm1UOWJaMFVSWTlWV2RSX3JSSXZlTkdY?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T23:08:26+00:00", "published_display": "16 Jul 2026 23:08", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences chief comm & corp aff officer sells $389,757 in stock By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNOF9sTldncUxBeDF2WXFWU2FXdDVIMndFMlFaOHQ3SUZUbTU2bmdROEE4cWJ1MUtqcUE3T093MXVSVFBOM1R2cWN5SUVWbWNyQVhIOGdfVmlSc0NGdWZqNUNRZzRDZE1ZeGpwb1NJWGhVSUV2UmJiRDhxVGc0ZUFwVDFQdTdrUzdrSlN4bWNCQ0NoT25TYkg5bVlSRDR0dElkaU5RSEd6a0F2R193N0VCejByM2NYUkNwai1rYzY5MnhLODl2ZkE?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-07-16T22:21:52+00:00", "published_display": "16 Jul 2026 22:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Inc (GILD) Stock Up 3.5% but GF Value Says Overv", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxObUJabGVPbXJTRnMycU9vSmp1Q0RCZExIZUNPbUhMbno0QW1tTllEYnNoOU1KS3k5TGFNYlc0RU5EMlRYMGpKbFRFUHdnQzFaX0prLWxJTHduRldEYnkzeDRUd25DZjRlS3o1Z19JcElPemNQamNTSl9FRDdEUFo2Y0tqQlNDaGFJWS16OUZQVjJyeWZncjlOM1gxNUpSQnJuMkNEc0JvdDRndmVZTThoLXpNOXE3ejNIb1dV?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T21:35:27+00:00", "published_display": "16 Jul 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look at Gilead Sciences Inc (GILD) After 3.7% Decline -- GF Va", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNeUd1bkVMbTFpMVI5QUEzdFByTHN4b1FLZVZUS1ZXbjRISGUzampEemMxa3VQdXVkckdHQnVva3MwOWNDdjRSZU02QTNGVE9SalF4R2R5WFg5cnVIN3RKU3J3V1RrM2laUDllRzNiWE1WaUlDYTVaaVRvS1VWaHd6U1NKVmdMUW9NMFlGTkJpZFpPMXNQSmZwaFZ4LTExYVZWUnZ4MlVqalpjUXVkQTFGUkNjMUtuTzdJZDVsdGVkZXVEOWJDaWFMVzFqSQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-10T21:24:14+00:00", "published_display": "10 Jul 2026 21:24", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Johanna Mercier Sells 3,000 Shares of Gilead Scien", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQS0JEQVlHbk01WDlsbnhYMkg3QVhNZDFEUFd1SGVveHkxSzVTWDhxazN1dEJvYTdTMEVKcER2UWJKVUQxMGV0TzFYcnRIYWllUW9zSHYwOE9oeDRtdlJWTFl4YjlXMHJhY2doa2JuY1RIQUxxT1NQdGZKVFdZajBoMjR1UUo2cmRyYWRoSnhMVzBNOG50S3M4b2JhelFYOTRVaGkyQngxaE55VmtmMUYzZmlJMHM5TE56RzR6eWYtTEU4TFU?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Daniel O'Day Sells 15,000 Shares of Gilead Sciences Inc (GILD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQWXBuQU92NGVfOGIzMVJjaFl2UzVmY3ZPZktmaUI4Z194S0cxMDg3T0lCVWROdV8wUld5aF9Ua1ZHQkM2RVJsN3NNRW1xMlpFai0zUEdQNUJXU18wZnQ0X2dKLXRRV2JMelJrTzFVUk1YbzZmRlpUelFjS2VCMFd0VWJ2dHg3bjdsRERQeWsxcl9xOU53RVA3OGIya1NpTTNtdlBWMlZ5dFBBZFN0bUV0QXpWaEFURklNRWlSX2tsZEhfY2xhZ1JYNVRIRXVLbTh0cENldA?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Reports Strong Q1 2026 Earnings and Raises Sales Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPZFNGNmpFU1hndi12dG1yNzlickgwX3J5VkxFdkpqZXZfb3dVVTV5SWpUN19JUFBmYUpTQUhtdF9jZk5QWDl4LTdfVHlzZDJxTTBPTHI2clpFbUZMVWhoeVYtRThVeXI2ZUZjaVc5Y2NjbEZFZlNrYlNDS3NuUmw1RVZkY3YwWjNKYVFQcmo4RFpRdHpiZk1pY08zcDJMM21Ub3ZNN2RSekRuVlRyNTFQSFBHZXBKamk2SVJXTmdnZ0JkRDBURFVOeA?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Stock Outlook: Is Wall Street Bullish or Bearish?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOOGNnUEttRXREWXJQRjdNd3MzRmswdlA2VjJqMGhadnRzYUdIdG14NGdmQmdybnN5SENoeHVRWExMR2R1eGRkZThBeGxmZUEweVhUbTNsSnQ3NnQzUjdUYUxmUzNyNDNlNmJBWXI3N3d5Mm1yUWlVWW42YlB0OGd3aTZaZmdaME04V3JnZDRfYzhURFVBcWtCN0xjZ2tRb3dlMDlRdEx4MVdaTW8?oc=5", "source_name": "Barchart.com", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences to acquire Ouro Medicines, expanding autoimmune therapy portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxOSXZZV054UjFMS0JyZU85R1JUdnVrOUcyRjlOTVVkb19aNGZaOXBWeVYtQ1ZVampka05DRzNuTmpSREw2ai1yUWhKV090dG9mQnVxYUNpU2pnTEplWlF4RE1oaUVsRTBGX1M5TnUtb193aGhqa21aUHA0MEdmUkZ6N3dlNG8wNWttTWc1aUF5bmtfS1ZtVGdxZndNclNfSmFualRlWmFGR2JQNjI2RnA2VGNKVWJCN2xwU1NRSFIzaU5kZEh2T09zR3ZjS3lqYUZ5ZVdDa3pJZDA4QWhqU0Qyazl4TzlSZw?oc=5", "source_name": "Proactive financial news", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxNSHF3TjZVc0plaEN3eU5QdFY0UGhrN3UwTnBVZmVweW4yOGw0a0ZETDBrWHdPQ1luanBsdG9fQTRSbXI5aDNuTTgxV2p2anlzOEJ0bEJ0cGh2b2JBc1U5UFY1M2l6amxFc2l0bmliMkx4czNBRmN0dEFTcktjeVN1eU5oVVMzb2IxbUtPZENvWGw5RXc0RjBmOUdMVUd4RTh6OVJzN3BfcWo2a0QxUE9BWGdJckEwSFRSRlpoWnpNbG5ZcE5PVUdrWFZSN0pmVldGN3Y3SmktSU1Dd05NdkZyTWdGc0FjaEx6Z1NndHo3VFd0SFRj?oc=5", "source_name": "PR Newswire", "published_at": "2025-07-22T07:00:00+00:00", "published_display": "22 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead commits to HIV prevention rollout for low-income countries despite funding uncertainty", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxQdTJtdkdTb0JvbXNVeElyQkFzN2JLRy0yQXhPWkYyaXU0Rms4d2NfRVl6MnZaeEI5emp2Y1VCM0k3cWZnT181QURLOUtiZXJrMmxRLURKaEs3WkliblEtNmlsM0txSTc0eU1MT1NiLWtTZTI2c1E1UXhGbjBRQ3pjS3ZqTWRIRnA3bWk4NTI5VjZNQnJHTlk3NlVvcFFPOWF2N3RSYllNTVpEeUdvREl6c0IzeXduOUpEVnZyR0I0TE52cDRNVnA4dXdUVjZETFpGdjRvMTVGQU5SRVRQcTRj?oc=5", "source_name": "Reuters", "published_at": "2025-05-30T07:00:00+00:00", "published_display": "30 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GILEAD SCIENCES APPOINTS PAUL PETRELLI TO VICE PRESIDENT AND GENERAL MANAGER IN CANADA", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxONm5PVmQ2Zjl1MjdabUlSMVE2NDFUTUI0bnpCNWxXUkN2N2ROb0dVbFotNnBwelRhYnlaYTdVeTZDWUFkaU0wZWJQRVpKTjhPbnhmRUlzTFBzOXg5RER5Rl90YV9NN21oUlNDY3hZb2ZleFRrQUQyUXlIN3F2ZnJMN1psMnBIZ2l2NFM5Y2t6U0hNMjZ0Tm12ekxhTmQ0d2h0QkNEeDlqdm85ZHBZZ0xxMHM3X1M2YVBZazEyYUZQYVVZVnZJOGtEVG11TkhwNnp1SVJfMHlB?oc=5", "source_name": "PR Newswire Canada", "published_at": "2024-11-07T08:00:00+00:00", "published_display": "07 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Inc (GILD:UW): Stock Price, Quote and News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE9IVGpORkxhRm1oN3hiY0FMLTlNb2RMemFWeGdNYzJfSGNhcGQ2NFFvUXNVRmF5WUl0NXk0eF94TFo0RnY1RmZHQ1oyOW9IWkpUWk1WUQ?oc=5", "source_name": "BNN Bloomberg", "published_at": "2024-07-30T16:12:03+00:00", "published_display": "30 Jul 2024 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brazil court strips Gilead of hepatitis C drug patent", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOYU85Z3NlWXk0TVk4TjVINDM4RWcycUxzYmhFdVVOMWk1eUVtTGtJc3loTEhmdlJRZ0FIcHd2bDBTWFJWNC1zZFdXQWkzRmlPak4tZlFSNnpJdVU4SUlrM0t3dWxMaVJJN3lGUU5OMDctOGR0X0tVSjdSa3RRSEtDRzlCd3J5OVcxQ0M5VXhzMFQ3X2c5N1MtOWJKblRoa2dZX3BIWm1CeE5xZWlyc2tIRHFfVE9JYmYxOHphTFlNamhLWVZpOS1LRXBvZWduSndpSFE?oc=5", "source_name": "Reuters", "published_at": "2018-09-24T07:00:00+00:00", "published_display": "24 Sep 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 69, "total_relevant": 14, "sentiment_summary": {"positive": 1, "negative": 4, "neutral": 9, "score": 47, "total": 14, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 91, "events": [{"event": "general", "label": "Market update", "weight": 7.65, "count": 12}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 332.38, "latest_week": "2026-07-10", "one_week_move": -3.0, "four_week_move": 4.9, "twelve_week_move": -3.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.252355, "market_dynamics_buy_signal": false, "relative_strength": -9.166152, "fair_value_gap": 27.9, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 50.3275, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.0% over one week, +4.9% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "GuruFocus", "count": 6}, {"label": "Reuters", "count": 2}, {"label": "Investing.com South Africa", "count": 1}, {"label": "Barchart.com", "count": 1}, {"label": "Proactive financial news", "count": 1}, {"label": "PR Newswire", "count": 1}, {"label": "PR Newswire Canada", "count": 1}, {"label": "BNN Bloomberg", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 14}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Earnings", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "47/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "91/100 classification confidence."}, {"label": "Company focus", "value": "14", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.0% over one week, +4.9% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Insider Sell: Johanna Mercier Sells Shares of Gilead Sciences In"}], "updated_at": "2026-07-18T00:25:49.904639+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}